You just read:

INOVIO's COVID-19 DNA Vaccine INO-4800 Demonstrates Robust Neutralizing Antibody and T Cell Immune Responses in Preclinical Models

News provided by

INOVIO Pharmaceuticals, Inc.

May 20, 2020, 07:00 ET